Concordance of the Quotient Attention Deficit Hyperactivity Disorder (ADHD) System Report With Teacher and Parent Assessments for Symptoms of ADHD

BioBehavioral Diagnostics Company

Overview

To demonstrate concordance between the Quotient ADHD System Report and standard DSM-IV based parent and teacher reported rating/assessment scales, currently the accepted method of symptom measurement for subjects diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).

Public school based study for children ages 8 through 14 years of age. Children previously identified and currently receiving an Individualized Education Program (IEP) or 504 accommodations in the classroom setting for symptoms of ADHD. Open enrollment of 30 subjects, both male and female. One study visit in which subjects will perform/receive the following assessments/evaluations: 1. Quotient ADHD System Test 2. Vanderbilt ADHD Diagnostic Teacher Rating Scale 3. Vanderbilt ADHD Diagnostic Parent Rating Scale The primary analytical goal is to examine the extent of agreement of the Quotient ADHD System(either individual measures or in combination) with standard measures (Vanderbilt ADHD Diagnostic Teacher Rating Scale and Vanderbilt ADHD Diagnostic Parent Rating Scale) and to compare this agreement with that seen between the standard measures.

Study Type

OBSERVATIONAL

Conditions

Attention Deficit Hyperactivity Disorder

Eligibility

Sex: ALLMin age: 8 YearsMax age: 14 Years

Medical Language ↔ Plain English

Inclusion Criteria: * A student attending one of three public elementary schools in the New Hampshire School Administrative Unit #44. * Age 8 through 14 years old at time of enrollment. * Pre-identified as receiving an Individualized Education Program (IEP) or 504 accommodations for symptoms of ADHD in the school setting by the Special Education Coordinator in the school district. * A parent/guardian of the child must be willing to participate. Exclusion Criteria: * No subject will be excluded from participation based on race, ethnicity, or gender. Anyone meeting inclusion criteria, who are willing to sign consent and participate, will be included in the study.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.